AstraZeneca

AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biotechnology company founded in 1999, partnering with SandboxAQ (Alphabet spinoff) in June 2023 to use quantum-inspired AI drug discovery and development tools reducing time and cost of bringing life-saving treatments to clinic. AstraZeneca uses SandboxAQ's AQ-FEP software combining quantum mechanical equations accuracy with AI speed and power on classical computing hardware for treatments for cancer, Alzheimer's, Parkinson's, and other conditions. In June 2025, AstraZeneca joined collaborative research program with IonQ, AWS, and NVIDIA developing quantum-accelerated computational chemistry workflow delivering 20x speedup in time-to-solution compared to prior benchmarks. AstraZeneca applies quantum computing to molecular simulations, drug-target binding calculations, and pharmaceutical R&D optimization. AstraZeneca serves global pharmaceutical market requiring quantum-enhanced drug discovery, computational chemistry, and AI-accelerated pharmaceutical development for breakthrough treatments.